wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33422543-705E1CB4-5AEB-4228-8367-DF7144E36E0E
Q33422543-705E1CB4-5AEB-4228-8367-DF7144E36E0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422543-705E1CB4-5AEB-4228-8367-DF7144E36E0E
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies
P1476
Q33422543-705E1CB4-5AEB-4228-8367-DF7144E36E0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422543-705E1CB4-5AEB-4228-8367-DF7144E36E0E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d7ab975b2c3f71d26db42360790970f5805f52cc
P1476
Phase 1 study of the safety, p
......
ry CD20+ lymphoid malignancies
@en